Answers are grounded in this paper and cite their sources.
Editorial on the Research Topic Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug developmentThe recent emergence of multiple zoonotic viruses such as Ebola virus and severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) have demonstrated that viruses of animal origin are a realistic threat to global public health.One of the pressing questions at the moment is how prepared we are in terms of development of therapeutic strategies in case of another pandemic.Assessing the risk of animal-to-human spillover for each of the viruses and identifying the targets for countermeasure initiatives can in long run reduce the economic and health impacts of emerging diseases.While it is incontestable that viruses need to be prioritized, for a focused global drug discovery strategy, based on their pandemic potential, ranking the risk of animal-to-human spillover is not an easy task.There have been several attempts to rank viruses based on their zoonotic potential, host, various factors about the virus, environment and related human behavior (Trock et al., 2015;Geoghegan et al., 2016;Olival et al., 2017).According to a recently developed viral risk ranking framework, Lassa virus, SARS-CoV-2, Ebola virus, Seoul virus, and Nipah virus are among the viruses that have the highest risk of zoonotic jump (Grange et al., 2021).Interestingly, several of the viruses that are identified as viruses of pandemic potential are RNA viruses (Carrasco-Hernandez et al., 2017).RNA viruses are characterized by compact genomes and a high mutation rate (10 -3 -10 -5 errors per nucleotide and replication cycle), generating changeswhich can usually occur due to replication errors as well as part of the evolutionary mechanisms of viruses (Dolan et al., 2018).While big data and machine learning have generated several methodologies that could be useful for infectious diseases intelligence, a parallel stream of efforts to identify effective druggable targets in these pathogens, and discovery and development of therapeutic agents against these targets could be crucial for an effective pandemic preparedness strategy.Drugs
No takes yet. Share an insight, caveat, or question.
Krishna Mohan Das (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: